ABL1 and leukemia: To get insight into this issue, we have used cyclophosphamide-induced immunocompromised BALB/c mice and xenografted intravenously with (Philadelphia-positive) BCR-ABL Ba/F3 leukemia cells to test whether the T2 combo can ameliorate leukemic mice model.